Generics - AstraZeneca

Filter

Current filters:

AstraZeneca

Popular Filters

1201 to 1225 of 1523 results

US Admin and GPhA moves to prevent drug shortages

18-12-2011

In response to US President Barack Obama’s Executive Order of October 31 (The Pharma Letter November…

GenericsMarkets & MarketingNorth AmericaPharmaceuticalRegulation

Australia’s new PBS prices will drive significant savings, says GMiA

18-12-2011

The new prices for medicines affected by the price disclosure policy on the Australian Pharmaceutical…

Asia-PacificGenericsPharmaceuticalPricing

Covidien to spin off pharmaceuticals business

16-12-2011

US medical products and generic drugmaker Covidien (NYSE: COV) says that it plans to spin off its pharmaceuticals…

CovidienGenericsMergers & AcquisitionsNeurologicalPharmaceutical

Australia’s generics sector stresses need for sustainable PBS

14-12-2011

Ensuring the Pharmaceutical Benefits Scheme (PBS) is sustainable and medicines remain affordable and…

Asia-PacificGenericsHealthcarePoliticsPricing

Mixed NICE views on Faslodex and RoActemra

14-12-2011

There was mixed news this morning from the UK’s National Institute for Health and Clinical Excellence…

Anti-Arthritics/RheumaticsAstraZenecaEuropeFaslodexOncologyPharmaceuticalPricingRegulationRoActemraRoche

AstraZeneca sells imaging agent rights

13-12-2011

Anglo-Swedish drug major AstraZeneca (LSE: AZN) has out-licensed AZD4694, its late-stage radiopharmaceutical…

AstraZenecaLicensingNeoprobeNeurologicalPharmaceutical

Management changes at Mylan, Transition Thera, Pfizer and ShangPharma

12-12-2011

US generic drug major Mylan (Nasdaq: MYL) has announced the appointment of John Thievon as president…

GenericsManagementMylan LaboratoriesPharmaceuticalShangPharmaTransition Therapeutics

Economics of Generics, according to Zacks

11-12-2011

Besides the multitude of the world’s poor, the aging population (2 billion people of 60 years or…

GenericsGlobalHealthcareMarkets & MarketingPatents

GMiA welcomes TGA blueprint for reform

11-12-2011

Australia’s Generic Medicines Industry Association (GMiA) says it welcomes the release last week…

Asia-PacificGenericsPoliticsRegulation

AstraZeneca expands in China, cuts back in USA

08-12-2011

It was a busy couple of days for Anglo-Swedish drug major AstraZeneca (LSE: AZN), with the company yesterday…

Asia-PacificAstraZenecaGenericsGuangdong BeiKang PharmaManagementMergers & AcquisitionsNorth AmericaPharmaceutical

FDA plans biosimilars user fee talks

08-12-2011

The US Food and Drug Administration has published a Federal Register notice announcing a December 16…

BiotechnologyFinancialGenericsNorth AmericaRegulation

Generic strategic alliances

07-12-2011

The generic drugs sector’s role as the provider of affordable drugs has widely benefitted public…

GenericsMergers & Acquisitions

NSCL cancer drug market set to grow 2.5% a year between 2010 and 2020, despite generic erosion

06-12-2011

Despite the arrival of generic competition – and ensuing sales erosion for several key agents used…

GenericsMarkets & MarketingOncologyPharmaceutical

AstraZeneca unlocks medical research cupboard to academia, as UK plans boost for pharma sector

05-12-2011

In a ground-breaking scientific collaboration, Anglo-Swedish drug major AstraZeneca (LSE: AZN) this morning…

AstraZenecaEuropeFinancialPharmaceuticalResearch

Actavis acquires Dutch company PharmaPack

04-12-2011

Iceland-headquartered generic drugmaker Actavis says it has acquired 100% of the shares in PharmaPack…

ActavisGenericsMergers & AcquisitionsPharmaPack

US Senators question Pfizer deals to limit access to generic Lipitor

02-12-2011

Three prominent US Senators have sent letters to pharma behemoth Pfizer (NYSE: PF), as well as three…

Cardio-vascularGenericsNorth AmericaPfizerPharmaceuticalPoliticsPricing

Brazilian acute coronary syndrome drug market set to nearly double to $229 million in 2015

01-12-2011

The acute coronary syndrome (ACS) drug market in Brazil will nearly double from $122 million in 2010…

AstraZenecaBrilintaCardio-vascularEffientEli LillyMarkets & MarketingPharmaceuticalSouth America

US launch of generic Lipitor confirms value of competition, says GPhA

01-12-2011

Commenting on this week’s US roll out for generic copies of Pfizer blockbuster cholesterol lowerer…

GenericsLipitorMarkets & MarketingNorth AmericaPatentsPfizerRanbaxy LaboratoriesWatson Pharmaceuticals

Actavis to boost oncology presence in Turkey, with generic drug launches

30-11-2011

Iceland-headquartered generic drugmaker Actavis is planning to increase its presence in Turkey next year…

ActavisEuropeGenericsMarkets & MarketingOncology

Further $100 million committed to AstraZeneca’s MedImmune Ventures

29-11-2011

Anglo-Swedish drug major AstraZeneca (LSE: AZN) revealed yesterday that it has committed an additional…

AstraZenecaFinancialMedImmuneMergers & AcquisitionsPharmaceutical

EC approves additional use for Bristol-Myers and AstraZeneca’s Onglyza and Komboglyze

29-11-2011

The European Commission has approved drug majors Bristol-Myers Squibb (NYSE: BMY) and AstraZeneca’s…

AstraZenecaBristol-Myers SquibbDiabetesEuropeKomboglyzeOnglyzaPharmaceuticalResearch

1201 to 1225 of 1523 results

Back to top